Related Experiment Video
Updated: Mar 6, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Eosinophilic colitis in children.
Urszula Grzybowska-Chlebowczyk1, Sabina Horowska-Ziaja2, Maciej Kajor3
1Department of Pediatrics, School of Medicine, Medical University of Silesia, Katowice, Poland.
Eosinophilic colitis in children often co-occurs with inflammatory bowel disease, particularly Crohn's disease. Severity of eosinophilic infiltration correlates with clinical symptoms and endoscopic findings, highlighting the need for comprehensive allergy and IBD diagnostics.
Area of Science:
- Pediatric Gastroenterology
- Allergy and Immunology
Background:
- Eosinophilic colitis is a rare gastrointestinal disease characterized by eosinophil infiltration of the colon wall.
- It can be primary or secondary to conditions like infections, inflammatory bowel disease (IBD), celiac disease, and vasculitis.
Purpose of the Study:
- To analyze the clinical and endoscopic presentation of eosinophilic colitis in children.
- To investigate the correlation between eosinophilic infiltration, comorbidities (IBD, food allergies), and clinical severity.
Main Methods:
- Study included 43 children diagnosed with eosinophilic colitis (Whitington scale).
- Evaluated food allergies, celiac disease, IBD, and parasitic infections.
- Assessed eosinophilic infiltration, clinical symptoms, endoscopic findings, and antibody levels (IgE, ASCA, ANCA).
Main Results:
- Half of the children had isolated eosinophilic colitis; the other half had co-existing IBD, predominantly Crohn's disease.
- Endoscopic findings were often uncharacteristic; grade III infiltration was common.
- Eosinophilic infiltration severity correlated with clinical exacerbations, endoscopic appearance, and IBD presence.
- Elevated ASCA/ANCA antibodies were noted in children with Crohn's disease and some with isolated eosinophilic colitis.
Conclusions:
- The findings underscore the need for improved allergy diagnostics, including IgE-independent mechanisms.
- Higher ASCA/ANCA levels in some isolated eosinophilic colitis cases suggest a need for monitoring for IBD development.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

